Primary atherogenic lipoprotein. Target for statin therapy. Calculated via Friedewald equation or measured directly.
| Sex | Age | Range | Notes |
|---|---|---|---|
| All | ≥ 18 yrs | < 3 | Optimal <3.0; high CV risk target <2.0; very high risk <1.4 (ESC 2019) |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.